Skip to main content
. 2020 Apr;8(7):446. doi: 10.21037/atm.2020.03.163

Figure S1.

Figure S1

Diagram of patients included in this study from the MSK-IMPACT cohort. The original report was published in 2017 and updated in 2019 with important follow-up data from patients treated with at least one dose of an immune checkpoint inhibitor (ICI). Matched patients from ten cancer types were divided into an ICI group and a non-ICI group based on whether they were treated with ICIs.